ACTRN12608000222347已完成未知
Randomised, double-blind, placebo-controlled intervention trial investigating the effect of iodine supplementation on cognition in school aged children
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 262
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 10 Years 至 13 Years(—)
- 性别
- All
入选标准
- •10-12 years of age
- •no thyroid disease
- •not taking iodine-containing supplements
排除标准
- •thyroid disease
- •taking iodine-containing supplements
研究者
相似试验
尚未招募
不适用
Clinical Study for antioxidant effects of aroniaKCT0003013JBKLAB70
进行中(未招募)
不适用
Prospective clinical study, where patients are receiving or the study drug or an inactive drug called placebo wihtout knowing which of the two drugs is taken, even the Investigator is aware of the therapy taken by the patients. Patients are assigned to a specific treatment according to a randomization list. The study is performed to assess the effects and tolerability of K(D)PT in ulcerative colitis.mild to moderate ulcerative colitisMedDRA version: 14.1Level: SOCClassification code 10017947Term: Gastrointestinal disordersSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-002462-20-ITDR. AUGUST WOLFF GMBH & CO. KG160
进行中(未招募)
不适用
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisEUCTR2011-002462-20-PLDr August Wolff GmbH & Co KG Arzneimittel160
进行中(未招募)
不适用
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisEUCTR2011-002462-20-HUDr August Wolff GmbH & Co KG Arzneimittel
进行中(未招募)
不适用
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisAcute mild to moderate ulcerative colitis.MedDRA version: 14.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-002462-20-SKDr August Wolff GmbH & Co KG Arzneimittel
